Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 6—June 2005

Research

Community-associated Methicillin-resistant Staphylococcus aureus in Hospital Nursery and Maternity Units

Simona Bratu*, Antonella Eramo†, Robert Kopec‡, Elizabeth Coughlin‡, Monica Ghitan‡, Robert Yost‡, Edward K. Chapnick‡, David Landman*Comments to Author , and John Quale*
Author affiliations: *State University of New York-Downstate, Brooklyn, New York, USA; †Long Island College Hospital, Brooklyn, New York, USA; ‡Maimonides Medical Center, Brooklyn, New York, USA

Main Article

Table 2

Susceptibility data on Staphylococcus aureus isolates collected from 11 to 15 hospitals in 1999, 2001, and 2003*

1999 (N = 567) 2001 (N = 772) 2003 (N = 588)
% MRSA 36 46 52
Antimicrobial agent (% susceptible)
Azithromycin 14 5 5
Clindamycin 18 15 20
Vancomycin 100 100 100
Daptomycin ND 100 100
Tigecycline ND ND 100
Minocycline 98 ND 98
Linezolid 100 ND 100
Rifampin 88 92 95
Imipenem 37 49 56
Ciprofloxacin 10 8 7
Trimethoprim-sulfamethoxazole 75 80 89

*MRSA, methicillin-resistant Staphylococcus aureus; ND, not done.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO